-
Symbol
-
KTTA on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
83.9K shares
-
Security Ownership
-
3.1%
Lawrence Steinman ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)
2025-03-06 - Lawrence Steinman has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 83.9K shares of Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
This represents 3.1% percent ownership of the company.